A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (M
Awarded By
Contributors
- Inman, Brant Allen Principal Investigator
Start/End
- August 9, 2021 - July 31, 2028